{"id":"W2561740607","doi":"10.1182/blood.v110.11.1450.1450","title":"Preliminary Results of a Phase II Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults with Myelodysplastic Syndrome (MDS).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Decitabine; Medicine; International Prognostic Scoring System; Regimen; Internal medicine; Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Phases of clinical research; Clinical endpoint; Bone marrow; Surgery; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002569192,0.00145552,0.001747249,0.0003839878,0.0004979373,0.0006671196,0.0008470769,0.001179472,0.00262077],"category_scores_gemma":[0.001236315,0.0005817724,0.001041575,0.0002906914,0.0007194137,0.0006170971,0.0003225595,0.003099357,0.0007232144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004442408,"about_ca_system_score_gemma":0.001158219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001186579,"about_ca_topic_score_gemma":0.002702995,"domain_scores_codex":[0.9994009,0.0003491333,0.00002943511,0.00007001657,0.00004067728,0.0001099866],"domain_scores_gemma":[0.9989004,0.0002513319,0.0001574743,0.00009273351,0.00008004679,0.0005180257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4831267,0.2563188,0.006694777,0.0007881047,0.001213032,0.0006241676,0.0007301042,0.002894442,0.1405434,0.0002889345,0.006163422,0.1006141],"study_design_scores_gemma":[0.1815518,0.7989318,0.01044865,0.00002358729,0.0002826045,0.0002157695,0.0000501252,0.0007138359,0.005358068,0.0001184636,0.002286568,0.00001867706],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879885,0.001910987,0.001474593,0.0006362612,0.0001804554,0.004063233,0.001986719,0.0001282599,0.001631038],"genre_scores_gemma":[0.9806738,0.002046258,0.00419754,0.001244875,0.0002630939,0.003929337,0.004024603,0.0000522459,0.003568261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00262077,"threshold_uncertainty_score":0.01358736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02123637865387349,"score_gpt":0.3115170207281743,"score_spread":0.2902806420743008,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}